MASH: Natural History , Life Style and Large Real World Data (1)

Nov 10 2025
Convention Center: Ballroom A, Level 3
2:00 PM - 3:30 PM

World Class Speakers

Zobair M Younossi, MD, MPH, FAASLD
Abstract Presenter

Zobair M Younossi, MD, MPH, FAASLD
Ludovic Saba, MD, MSc
Abstract Presenter

Ludovic Saba, MD, MSc

UT Southwestern Medical Center
Manal F Abdelmalek, MD, MPH, FAASLD
Abstract Presenter

Manal F Abdelmalek, MD, MPH, FAASLD

Mayo Clinic Rochester
Vincent Chen, MD
Moderator

Vincent Chen, MD

University of Michigan Medical Center
Manal F Abdelmalek, MD, MPH, FAASLD
Moderator

Manal F Abdelmalek, MD, MPH, FAASLD

Mayo Clinic Rochester

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

2:00 PM - 2:15 PM
Apr 29 2026
Washington, D.C.

The Impact of Metabolic Risks and Alcohol Use on Disease Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Zobair M Younossi, MD, MPH, FAASLD , Abstract Presenter
MASLD
2:30 PM - 2:45 PM
Apr 29 2026
Washington, D.C.

Comparative Analysis of Semaglutide and Tirzepatide Use in Persons with MASLD: Implications for Progression to Cirrhosis and Complications

Ludovic Saba, MD, MSc , Abstract Presenter
MASLD
2:45 PM - 3:00 PM
Apr 29 2026
Washington, D.C.

Real-world clinical and economic outcomes by fibrosis stage in patients with metabolic dysfunction–associated steatohepatitis (MASH)

Manal F Abdelmalek, MD, MPH, FAASLD , Abstract Presenter
MASLD

Objectives

  • Describe the natural history and progression patterns of MASH, including risk factors for fibrosis advancement and liver-related outcomes.
  • Analyze findings from large real-world data sets to identify trends, gaps, and implications for patient management and future research.